Mar 11, 2020
WuXi AppTec Wuhan Site Resumes Operation
Jan 02, 2020
WuXi STA Opens Oligonucleotide Large-Scale Manufacturing Facility
Nov 14, 2019
WuXi AppTec Receives 2019 Global Integrated Drug Development Competitive Strategy Innovation & Leadership Award from Frost & Sullivan
Nov 10, 2019
Dr. Ge Li Awarded "CEO of the Year" at CPhI Worldwide 2019
Nov 06, 2019
WuXi AppTec Receives Investment Grade Corporate Ratings from Three Global Rating Agencies
Oct 10, 2019
WuXi AppTec Research Service Division and BioSolveIT Introduce GalaXi®, a Vast New Chemical Space of Tangible Molecules
Aug 19, 2019
WuXi AppTec Reports First Half 2019 Interim Results
Jun 29, 2019
WuXi AppTec Named One of MIT Technology Review's 50 Smartest Companies
May 06, 2019
Scientific Advisory Board Announced for DELopen to Guide the Open Access DNA Encoded Library Interchange
May 05, 2019
WuXi AppTec Acquires Pharmapace to Enhance Biometrics Services for Clinical Development
Mar 22, 2019
WuXi AppTec Reports Strong 2018 Annual Results
Feb 18, 2019
WuXi STA and BioLingus sign exclusive technology and marketing collaboration for sublingual delivery
Dec 12, 2018
WuXi AppTec Lists H Shares on the Hong Kong Stock Exchange
Dec 10, 2018
WuXi AppTec Expands Site in California for Pharmaceutical R&D Services
Nov 27, 2018
WuXi AppTec Receives 2018 Global Integrated Drug R&D Services Competitive Strategy Innovation & Leadership Award from Frost & Sullivan
Nov 16, 2018
WuXi AppTec Opens Its New Medical Device Testing Center in Suzhou
Oct 22, 2018
China Electronics Data and WuXi AppTec Form CW Data, a Joint Venture to Offer One-Stop Healthcare Big Data Solutions
Oct 12, 2018
WuXi AppTec Provides Easy Access to 80 Billion DNA-Encoded Small Molecules Libraries
Aug 22, 2018
WuXi AppTec Appoints Edward Hu as Co-CEO
Jul 25, 2018
WuXi STA's Jinshan Site Passes Fourth U.S. FDA Inspection